Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
ORTX3 quarters
Position history for Qube Research & Technologies Ltd's holdings in ORCHARD THERAPEUTICS PLC
As of its Q4 2023 13F, Qube Research & Technologies held 172,579 shares of ORTX (Orchard Therapeutics), worth $2.8M. Qube Research & Technologies' 13F filings listed ORTX from Q3 2023 to Q4 2023, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$23
Total Shares Change
-3
Quarter-by-Quarter History
Other major holders of ORTX: FEDERATED HERMES, INC., LMR Partners LLP, TUDOR INVESTMENT CORP ET AL